Developed by scientists, for scientists, experience the superior hybridization-based approach of OGT's SureSeq™ portfolio for hematology, solid tumor and constitutional cytogenetics, with pre-designed and custom NGS solutions optimized for the enhanced detection of low-frequency SNVs and indels, as well as complex structural aberrations such as ITDs, PTDs, CNVs, LOH and translocations.
We can always rely on excellent assistance from OGT, starting from product selection to collaborative test implementation. Their invaluable support helped guide us through software installation, and working with OGT's Field Application Scientist, Peter Gray, helped address all of our inquiries promptly and comprehensively.
Anna Sobczyńska-Konefał
Head of the Department of Hemato-Oncology Diagnostics, Lower Silesian Center for Oncology, Pulmonology and Hematology, Poland